Literature DB >> 24070520

Stroke and renal dysfunction.

Tanja Hojs Fabjan1, Radovan Hojs2.   

Abstract

Stroke is the most frequent neurological disease and represents a continuously evolving medical and social problem. Chronic kidney disease (CKD) is also an important worldwide public health problem. Renal dysfunction carries a substantial risk of cardiovascular morbidity and mortality and an independent, graded association between renal function and cardiovascular events was found. In the last 15years the link between CKD and cerebrovascular disease has become more apparent. Patients with end stage renal disease treated with maintenance hemodialysis have a much higher incidence of stroke than the general population and stroke is one of the major causes of death in these patients. Nowadays ischemic subtype of stroke is present in approximately 70% of dialysis patients. In population based studies conflicting results have been reported about the association between stroke and CKD before replacement therapy. However, in high risk patients, defined by the presence of either cardiovascular disease or cardiovascular risk factors, different stages of CKD are clearly associated with subsequent stroke. In patients with stroke the exact prevalence of renal dysfunction is not known. Reported prevalence from a few published studies is up to 38% and it is higher than that in age-matched control groups. Furthermore, in patients suffering from stroke renal dysfunction is associated with short and long term mortality. The most effective treatment of stroke in patients with CKD is not known and further studies are needed.
© 2013.

Entities:  

Keywords:  Chronic kidney disease; End-stage renal failure; Mortality; Renal dysfunction; Stroke

Mesh:

Substances:

Year:  2013        PMID: 24070520     DOI: 10.1016/j.ejim.2013.08.710

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  8 in total

1.  Ischemic stroke: the impact of renal dysfunction on 1-year mortality.

Authors:  Tanja Hojs Fabjan; Radovan Hojs
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

Review 2.  Peripheral Organ Injury After Stroke.

Authors:  Jin Wang; Jiehua Zhang; Yingze Ye; Qingxue Xu; Yina Li; Shi Feng; Xiaoxing Xiong; Zhihong Jian; Lijuan Gu
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

3.  Reduced Stroke Risk After Parathyroidectomy in End-Stage Renal Disease: A 13-Year Population-Based Cohort Study.

Authors:  Yueh-Han Hsu; Hsuan-Ju Chen; Szu-Ching Shen; Wen-Chen Tsai; Chih-Cheng Hsu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation.

Authors:  Dan Liu; Kai Hu; Marie Schmidt; Jonas Müntze; Octavian Maniuc; Daniel Gensler; Daniel Oder; Tim Salinger; Frank Weidemann; Georg Ertl; Stefan Frantz; Christoph Wanner; Peter Nordbeck
Journal:  Clin Res Cardiol       Date:  2018-05-24       Impact factor: 5.460

Review 5.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

6.  Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).

Authors:  Adhish Agarwal; Alfred K Cheung; Jianing Ma; Monique Cho; Man Li
Journal:  J Am Heart Assoc       Date:  2019-08-19       Impact factor: 5.501

Review 7.  The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders.

Authors:  Maryam Assem; Mathilde Lando; Maria Grissi; Saïd Kamel; Ziad A Massy; Jean-Marc Chillon; Lucie Hénaut
Journal:  Toxins (Basel)       Date:  2018-07-22       Impact factor: 4.546

8.  Hyperglycemia is associated with poor in-hospital outcome in elderly patients with acute ischemic stroke.

Authors:  Lei Zhao; Li Wang; Meihua Lu; Wei Hu; Shuangling Xiu
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.